Esthetician to the Stars to Collaborate with Cellese Corporation in Promoting High Science Anti-aging Cosmeceutical
Certified Aesthetic Medical Specialist has three decade history of providing state of the art esthetic services to the “Who´s Who” of cinema, TV, music, and California politics
Irvine, CA (PRWEB) September 28, 2012
Cellese Corporation today announced “esthetician to the stars” Melissa Travis Aardema of Calabasas, California will immediately begin collaboration in marketing and educating the public about AnteAGE ® , Cellese´s newly launched adult human stem cell based anti-aging cosmeceutical. Ms. Aardema will be demonstrating the product in the Cellese booth at the BeWell Expo being held September 29 and 30 at the Los Angeles Convention Center.
“Ms. Aardema is a highly respected and knowledgeable professional who evaluated our product for over two months before agreeing to join our team”, said Dr. John Sanderson, the founder and CEO of Cellese. “She used it herself and on several clients before contacting us to tell us she was extremely impressed and wanted to help educate the public about it.”
With her biology training at Cal State Northridge and a love of all things beautiful, Melissa made a decision in 1984 that has taken her to some pretty amazing places, including up close and personal as esthetician to some of the biggest names in movies, television, music, and politics. The Calabasas, California resident respects the privacy of her clients too much to drop names but is quick to point out the list is pretty impressive.
“Academy award winners, action movie heroes, daytime soap and talk show stars, pop divas, rap moguls, directors, producers, even high elected officials – I´ve introduced dozens to the latest in skin care and esthetic medical procedures.”
Ms. Aardema has striven throughout her career to be on the cutting edge of her profession. “Just as facials were beginning to be appreciated by the medical community as beneficial for many types of skin disorders, I was beginning my practice” Aardema says. Because she emphasized “medical facials”, she was fortunate to work with some of the top dermatologists and plastic surgeons in Los Angeles, who soon began to refer their celebrity clients to her. Many remain her clients today.
When injectable fillers began to be used, Melissa was at the forefront of the trend, consulting and working with Collagen Corporation. Her expertise prompted Aesthetics International to hire her as a trainer and educator in 1985. She continues to work with some of the most notable brands in the industry.
Which is a major reason Cellese was anxious to get her opinion of its anti-aging cosmeceutical, according to Dr. George Taylor, Cellese Vice President of Business Development? “Cellese could not be more pleased. With her strong background in science, Melissa is a skeptic by nature and with her highly visible clientele, she had to be convinced we had a superior product. She´s convinced and is now introducing clients to AnteAGE®.”
Cellese markets its flagship product as the most advanced anti-aging cosmeceutical in the world, containing all the proven powerhouse anti-aging actives in addition to Cellese´s proprietary adult stem cell based ingredient. “There are 15 scientifically proven active ingredients, all with published peer-reviewed scientific validation of their value in promoting healthier younger looking skin. Early adopters are extremely pleased with results and are posting glowing reviews on the internet”, Taylor continued. “Many users find they can discard other products and rely on AnteAGE® , a gentle cleanser and a sun block for all their skincare needs.
Sanderson noted that several hundred early adopters have purchased AnteAGE® since the company started marketing efforts in April of this year. “We offer a money back guarantee and only one person has sought a refund. With a reorder rate well over 50% and people of Melissa´s caliber now wanting to join the team, we see a bright future ahead.”
For more information contact: info(at)cellese(dot)com or gtaylor(at)cellese(dot)com
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/9/prweb9949245.htm